50 related articles for article (PubMed ID: 6232804)
21. [Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].
Rodríguez JN; Fernández-Jurado A; Martino ML; Diéguez JC; Moreno MV; Quesada JA; Polo B; Cañavate M; Amian A; Prados D
Sangre (Barc); 1998 Feb; 43(1):35-9. PubMed ID: 9580427
[TBL] [Abstract][Full Text] [Related]
22. Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG).
Ohno R; Kobayashi T; Morishima Y; Hiraoka A; Imai K; Asoh N; Tsubaki K; Tomonaga M; Takahashi I; Kodera K
Leukemia; 1992; 6 Suppl 2():92-5. PubMed ID: 1578954
[TBL] [Abstract][Full Text] [Related]
23. Intensive short-term chemotherapy for patients with acute myelogenous leukemia: long-term follow-up.
Oblon DJ; Weiner RS; Kramer BS; Ross W; Noyes WD; Boyett J; Kitchens CS
Cancer Treat Rep; 1985 Dec; 69(12):1425-7. PubMed ID: 2416439
[TBL] [Abstract][Full Text] [Related]
24. Influence of daunorubicin and cytarabine sequencing on the outcome of therapy in acute myelogenous leukemia: a randomized trial.
Archimbaud E; Fiere D; Treille-Ritouet D; Adeleine P; Guyotat D; Sebban C; Vuvan H; Viala JJ
Cancer Treat Rep; 1987 Jun; 71(6):571-4. PubMed ID: 3555788
[TBL] [Abstract][Full Text] [Related]
25. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
[TBL] [Abstract][Full Text] [Related]
26. Acute nonlymphoblastic leukemia: prognostic factors in adults with long-term follow-up.
Passe S; Miké V; Mertelsmann R; Gee TS; Clarkson BD
Cancer; 1982 Oct; 50(8):1462-71. PubMed ID: 7116285
[TBL] [Abstract][Full Text] [Related]
27. [Massive bilateral subconjunctival hemorrhage revealing acute lymphoblastic leukemia].
Taamallah-Malek I; Chebbi A; Bouladi M; Nacef L; Bouguila H; Ayed S
J Fr Ophtalmol; 2013 Mar; 36(3):e45-8. PubMed ID: 23122838
[TBL] [Abstract][Full Text] [Related]
28. Angiokeratoma-like purpuric palmar nodules following chemotherapy.
Torre EA; Kersh AE; Fischer AS; Xu X; Rosenbach M; Shields BE
Dermatol Online J; 2021 Aug; 27(8):. PubMed ID: 34755962
[TBL] [Abstract][Full Text] [Related]
29. Long-term survivors of adult acute nonlymphocytic leukemia: fact or fiction?
Rosenthal DS; Emerson SE; Rappeport JM; Moloney WC; Handin RI
Haematol Blood Transfus; 1985; 29():44-7. PubMed ID: 3896974
[TBL] [Abstract][Full Text] [Related]
30. Consolidation therapy without maintenance for acute non-lymphoblastic leukaemia.
Roberts MM; Juttner CA; Blunden RW; Horvath N; To LB; Ho JQ; Dart GW; Kimber RJ
Med J Aust; 1988 Feb; 148(4):181-3. PubMed ID: 3340044
[TBL] [Abstract][Full Text] [Related]
31. Current status of treatment of acute leukemia in adults: an overview of the Memorial experience and review of literature.
Clarkson BD; Gee T; Arlin ZA; Mertelsmann R; Kempin SJ; Dinsmore RE; O'Reilly RJ; Andreeff M; Berman E; Little C
Crit Rev Oncol Hematol; 1986; 4(3):221-48. PubMed ID: 3513984
[TBL] [Abstract][Full Text] [Related]
32. Adult acute nonlymphocytic leukemia.
Cassileth PA
Med Clin North Am; 1984 May; 68(3):675-95. PubMed ID: 6379338
[TBL] [Abstract][Full Text] [Related]
33. [Lung survival or healing? Description of a case of acute non-lymphoblastic leukosis].
Delsignore R; Baroni MC; Mineo F; Crotti G; Butturini U
Acta Biomed Ateneo Parmense; 1984; 55(1):59-62. PubMed ID: 6232804
[TBL] [Abstract][Full Text] [Related]
34. Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.
Berman E; Arlin ZA; Gaynor J; Miller W; Gee T; Kempin SJ; Mertelsmann R; Andreeff M; Reich L; Nahmias N
Leukemia; 1989 Feb; 3(2):115-21. PubMed ID: 2911205
[TBL] [Abstract][Full Text] [Related]
35. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
